Dilution of Share Value from Stock Options
First written in FY2016. 6 of 15 entries say "Softened", first in FY2017. Latest entry: FY2027-H1.
The whole theme swung hardest in 2017: 37 of 68 companies on the "Worse" side.
- FY2027-H1Updated exercise results for the 10th and 12th stock acquisition rightsAnnual report
「Number of bonds with stock acquisition rights subject to exercise during the interim accounting period, including an exercise price adjustment clause (units) 1,999 23,999 Number of shares delivered upon exercise during the interim accounting period (shares) 199,900 2,399,900」
The 10th stock acquisition rights covering 199,900 shares and the 12th stock acquisition rights covering 2,399,900 shares were exercised, advancing the conversion of potential shares into issued shares. - FY2026WorsenedAnnual report
「As of the end of the consolidated fiscal year, the number of potential shares was 4,753,900, including 1,199,900 shares allocated to a third party, representing 8.2% of the total 58,025,700 issued shares.」
The potential share ratio rose from 6.4% in the previous fiscal year to 8.2%, increasing dilution exposure from the 10th and 11th stock acquisition rights and other rights. - FY2024SoftenedAnnual report
「As of the end of the consolidated fiscal year, the number of potential shares was 3,554,000, representing 6.4% of the total 55,225,600 issued shares.」
The potential share ratio declined from 6.5% in the previous fiscal year to 6.4%, although the possibility of dilution through the exercise of stock acquisition rights continues. - FY2023-Q2Updated dilution resulting from the exercise of stock acquisition rightsAnnual report
「Increase/decrease in total issued shares 30,000 55,225,600 (Note) The increase resulted from the exercise of stock acquisition rights.」
The number of shares increased by 30,000 through the exercise of stock acquisition rights, advancing the conversion of potential shares into issued shares. - FY2023-Q1Updated dilution resulting from the exercise of stock acquisition rightsAnnual report
「The number of issued shares increased by 15,000 through the exercise of the third series of stock acquisition rights (stock options).」
The number of shares increased by 15,000 through the exercise of stock acquisition rights, advancing the conversion of potential shares into issued shares. - FY2022WorsenedAnnual report
「As of the end of the consolidated fiscal year, the number of potential shares was 3,599,000, representing 6.5% of the total 55,180,600 issued shares.」
The number of potential shares, including the 9th stock acquisition rights and other rights, was 3,599,000, representing 6.5% of total issued shares, increasing dilution exposure from 2.4% in the previous fiscal year. - FY2022-Q2WorsenedAnnual report
「9th Stock Acquisition Rights (paid stock options with a share-price commitment)」
The 9th stock acquisition rights newly established 3,000,000 underlying common shares, increasing potential exposure to equity value dilution. - FY2021SoftenedAnnual report
「As of the end of the consolidated fiscal year, the number of potential shares was 1,308,000, representing 2.4% of the total 54,471,600 issued shares.」
The potential share ratio declined from 2.9% in the previous fiscal year to 2.4%. The possibility of dilution through the exercise of stock acquisition rights continues. - FY2020SoftenedAnnual report
「The Company has adopted a stock option scheme using stock acquisition rights. As of the end of the consolidated fiscal year, the number of potential shares was 1,323,000, representing 2.9% of the total 45,312,600 issued shares.」
The potential share ratio declined from 3.6% in the previous fiscal year to 2.9%. The possibility of dilution through the additional issuance and exercise of stock acquisition rights continues. - FY2020-Q3WorsenedAnnual report
「Number of potential shares from the issue 9,087,000 shares (100 shares per stock acquisition right)」
The issuance of the 6th through 8th stock acquisition rights newly resulted in 9,087,000 potential shares, increasing dilution exposure. - FY2019SoftenedAnnual report
「As of the end of the consolidated fiscal year, the number of potential shares was 1,323,000, representing 3.6% of the total 36,369,600 issued shares.」
The potential share ratio declined from 4.5% in the previous fiscal year to 3.6%. The possibility of dilution through the additional issuance and exercise of stock acquisition rights continues. - FY2019-Q3WorsenedAnnual report
「Maximum number of shares subject to allocation: 5,000,000 (15.94% of total issued shares)」
For the 5th stock acquisition rights, a maximum of 5 million potential shares, equivalent to 15.94% of total issued shares, was newly disclosed, increasing exposure to equity value dilution. - FY2018SoftenedAnnual report
「As of the end of the consolidated fiscal year, the number of potential shares was 1,393,000, representing 4.5% of the total 31,299,600 issued shares.」
The potential share ratio declined from 5.0% in the previous fiscal year to 4.5%, although the possibility of dilution of equity value upon exercise continues. - FY2017SoftenedAnnual report
「As of the end of the consolidated fiscal year, the number of potential shares was 1,545,000, representing 5.0% of the total 31,197,600 issued shares.」
The potential share ratio declined from the previously disclosed 8.1% to 5.0%. The possibility of additional stock acquisition rights being issued and dilution upon exercise continues to be disclosed. - FY2016First statedAnnual report
「As of the end of the consolidated fiscal year, the number of potential shares was 2,496,000, representing 8.1% of the total 30,956,600 issued shares.」
The disclosure shows 2,496,000 potential shares from stock options, equivalent to 8.1% of total issued shares, and identifies potential dilution of equity value upon exercise as a risk.